搜尋
Edap Tms SA
EDAP添加自選
4.420USD
+0.250+6.00%
收盤 05/18, 16:00（美東）報價延遲15分鐘
165.68M總市值
虧損本益比TTM
關於 Edap Tms SA 公司
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Edap Tms SA簡介
公司代碼EDAP
公司名稱Edap Tms SA
上市日期Aug 01, 1997
CEORhodes (Ryan)
員工數量310
證券類型Depository Receipt
年結日Aug 01
公司地址4, rue du Dauphine
城市VAULX-EN-VELIN
上市交易所NASDAQ OMX - NASDAQ BASIC
國家France
郵編69120
電話33472153150
網址https://focalone.com/fr/accueil/
公司代碼EDAP
上市日期Aug 01, 1997
CEORhodes (Ryan)
Edap Tms SA公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
1.53M
+80.34%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.34M
+6.99%
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
25.00K
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
5.10K
--
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
Ms. Blandine Confort
Ms. Blandine Confort
Investor Relations Officer, Director - Legal Affairs
Investor Relations Officer, Director - Legal Affairs
--
--
Mr. Francois Dietsch
Mr. Francois Dietsch
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Ken Mobeck
Mr. Ken Mobeck
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Glen French
Mr. Glen French
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Ryan Rhodes
Mr. Ryan Rhodes
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
Chief Executive Officer, Director, Chief Executive Officer of EDAP Technomed Inc
1.53M
+80.34%
Dr. Lance Willsey
Dr. Lance Willsey
Interim Independent Chairman of the Board
Interim Independent Chairman of the Board
1.34M
+6.99%
Mr. Joshua H. (Josh) Levine
Mr. Joshua H. (Josh) Levine
Independent Director
Independent Director
25.00K
--
Ms. Fran Schulz
Ms. Fran Schulz
Independent Director
Independent Director
5.10K
--
Herve De Soultrait
Herve De Soultrait
General Manager of EDAP Technomed (M) Sdn, Bhd
General Manager of EDAP Technomed (M) Sdn, Bhd
--
--
Mr. Jean-Francois Bachelard
Mr. Jean-Francois Bachelard
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
President and Chief Executive Officer of Edap Technomed Co Ltd (Japan)
--
--
收入明細
單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2024
由於公司未披露，未能獲取相關數據
地區USD
名稱
營收
佔比
Asia
19.04M
29.70%
United States
18.22M
28.42%
Other Geographical Areas
15.61M
24.35%
France
11.24M
17.53%
業務
地區
由於公司未披露，未能獲取相關數據
股東統計
更新時間: 4月17日 週五
更新時間: 4月17日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Soleus Capital Management, L.P.
19.50%
Morgan Stanley & Co. International Plc
8.94%
Rhodes (Ryan)
4.09%
Willsey (Lance)
3.56%
Rock Springs Capital Management LP
3.43%
其他
60.48%
持股股東
持股股東
佔比
Soleus Capital Management, L.P.
19.50%
Morgan Stanley & Co. International Plc
8.94%
Rhodes (Ryan)
4.09%
Willsey (Lance)
3.56%
Rock Springs Capital Management LP
3.43%
其他
60.48%
股東類型
持股股東
佔比
Hedge Fund
23.72%
Individual Investor
9.85%
Research Firm
9.02%
Investment Advisor
6.03%
Investment Advisor/Hedge Fund
0.08%
Bank and Trust
0.01%
其他
51.29%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
70
14.62M
39.01%
-711.40K
2025Q4
67
13.87M
40.98%
--
2025Q3
75
13.87M
43.87%
-275.79K
2025Q2
87
14.15M
45.65%
-604.14K
2025Q1
89
14.75M
47.73%
-3.10M
2024Q4
92
15.39M
47.99%
-286.99K
2024Q3
91
15.67M
50.30%
-364.48K
2024Q2
88
16.06M
51.11%
-201.29K
2024Q1
93
16.22M
51.99%
-3.07M
2023Q4
90
15.98M
53.82%
-494.00
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Soleus Capital Management, L.P.
7.31M
19.5%
--
--
Dec 31, 2025
Morgan Stanley & Co. International Plc
3.35M
8.94%
-9.70K
-0.29%
Dec 31, 2025
Rhodes (Ryan)
301.15K
0.8%
+301.15K
--
Jan 01, 2026
Willsey (Lance)
1.24M
3.31%
+1.24M
--
Jan 01, 2026
Rock Springs Capital Management LP
1.29M
3.43%
+16.50K
+1.30%
Dec 31, 2025
Flax Pond Capital LLC
797.25K
2.13%
+797.25K
--
Dec 31, 2025
Mobeck (Kenneth S.)
56.61K
0.15%
+56.61K
--
Jan 01, 2026
Bruce & Company, Inc.
438.65K
1.17%
--
--
Dec 31, 2025
UBS Financial Services, Inc.
207.76K
0.55%
-26.69K
-11.38%
Dec 31, 2025
Parkman Healthcare Partners LLC
154.83K
0.41%
--
--
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
ActivePassive International Equity ETF
0%
ActivePassive International Equity ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
